Saturday, July 12, 2025
HomeIndustriesBiotechnology

Biotechnology

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Lyra Therapeutics, Inc., a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained and local delivery of medications to the ear,...

Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology

Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced the recent exercise of Onward Therapeutics' second of three instalments of equity investment in...

Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...

Cizzle Biotechnology Announces Strategic Agreement with the Behnke Group to Enhance U.S. Market Presence

Cizzle Biotechnology Holdings PLC, the UK based diagnostics developer, is pleased to announce that it has entered into an agreement with the Behnke Group,...

Nonagen Bioscience Announces CE Mark for Oncuria Bladder Cancer Diagnostic

Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria immunoassay for bladder cancer. Oncuria is the first-of-its-kind multiplex urine test for the...
0FansLike
0FollowersFollow
spot_img

Hot Topics